During the past decade, Vancouver Island Health Authority conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 3 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vancouver Island Health Authority" #1 sponsor was "McMaster University" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Andrew Penn" with 2 trials sponsored, "TauRx Therapeutics Ltd" with 2 trials sponsored and "Vancouver Island Health Authority" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vancouver Island Health Authority" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 7 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Bruker Daltonics" with 2 trials as a collaborator, "Canadian Critical Care Trials Group" with 2 trials as a collaborator and "Genome Alberta" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Vancouver Island Health Authority" are "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (4 trials), "C-Difficile" (2 trials), "Dementia" (2 trials) and "TIA" (2 trials). Many other conditions were trialed in "Vancouver Island Health Authority" in a lesser frequency.

Most popular intervention types in "Vancouver Island Health Authority" are "Drug" (18 trials), "Other" (8 trials), "Biological" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Crenezumab" (2 trials), "L. rhamnosus GG - Probiotic" (2 trials), "Non-Interventional Study" (2 trials) and "Placebo - Microcrystalline Cellulose" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vancouver Island Health Authority" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Vancouver Island Health Authority". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Vancouver Island Health Authority, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Vancouver Island Health Authority, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".